GlassScriptPhysician profile
Asfand Yar Butt
NPI 1942819149
$680.84
in general payments reported to CMS, 2019-2025
15 companies · $157 in 2025
The $157 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $81.43 · 2022: $95.03 · 2023: $200 · 2024: $148 · 2025: $157.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $504.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $504.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $149.16 | 2023-2025 | |
| Intuitive Surgical, INC. | $129.46 | 2024 | |
| Abbvie INC. | $110.87 | 2021-2023 | Rinvoq |
| Regeneron Healthcare Solutions, INC. | $51.48 | 2025 | Dupixent |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $43.44 | 2021-2022 | |
| Immunitybio, INC. | $34.92 | 2025 | |
| United Therapeutics Corporation | $23.88 | 2025 | Tyvaso |
| Amgen INC. | $21.97 | 2025 | Tezspire |
| Lundbeck LLC | $19.33 | 2023 | Vyepti |
| Inspire Medical Systems, INC. | $18.40 | 2024 | Inspire |
| Sk Life Science, INC. | $18.06 | 2023 | |
| Irhythm Technologies, INC. | $17.19 | 2022 | |
| Novo Nordisk INC | $15.98 | 2021 | |
| Inari Medical, INC. | $14.33 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Alexion Pharmaceuticals, INC. | $12.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Asfand Yar Butt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.